| OAA0404 | Diverse envelope trimers with altered glycan coverage around the CD4-binding site elicit neutralizing antibodies of >50% breadth in NHPs | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0403 | Perturbation of mucosal granulocytic effector cells in lentivirus infections | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0402 | Novel V1 deleted-envelope vaccine based on VLP protects against SHIV infection | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0305 | Analysis of HIV transcribing cells from viremic and virally-suppressed individuals living with HIV using novel single-cell RNAseq method | Oral abstract session with live Q&A | HIV virology |
| OAA0304 | Hypoxic adaptation uncovers a glycolytic dependence of HIV-1 latency reversal | Oral abstract session with live Q&A | Understanding and targeting persistent HIV reservoirs |
| OAA0303 | Follicular T helper cells (TFH) are a minor source of the active HIV reservoir in secondary lymphoid tissues of people with HIV (PWH) on prolonged suppressive antiretroviral therapy (ART) | Oral abstract session with live Q&A | Understanding and targeting persistent HIV reservoirs |
| OAA0302 | Differential susceptibility of cells infected with defective and intact proviruses to HIV-selective cell killing by small molecule therapies | Oral abstract session with live Q&A | Understanding and targeting persistent HIV reservoirs |
| OAA0205 | Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers of rhesus macaques | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OAA0204 | The EZH2 inhibitor Tazemetostat increases MHC-I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OAA0203 | In vivo genome engineering of human T cells results in ART-free control of HIV-1 in humanized mice | Oral abstract session with live Q&A | Novel treatment and prevention strategies |